journal article·2011-09

Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles

C. Greulich, J. Diendorf, J. Geßmann, T. Simon, T. Habijan, G. Eggeler, T.A. Schildhauer, M. Epple, M. Köller

Acta Biomaterialia· Volume 7· Issue 9
Publisher page

Abstract

Silver nanoparticles (Ag-NP) are increasingly used in biomedical applications because of their remarkable antimicrobial activity. In biomedicine, Ag-NP are coated onto or embedded in wound dressings, surgical instruments and bone substitute biomaterials, such as silver-containing calcium phosphate cements. Free Ag-NP and silver ions are released from these coatings or after the degradation of a biomaterial, and may come into close contact with blood cells. Despite the widespread use of Ag-NP as an antimicrobial agent, there is a serious lack of information on the biological effects of Ag-NP on human blood cells. In this study, the uptake of Ag-NP by peripheral monocytes and lymphocytes (T-cells) was analyzed, and the influence of nanosilver on cell biological functions (proliferation, the expression of adhesion molecules, cytokine release and the generation of reactive oxygen species) was studied. After cell culture in the presence of monodispersed Ag-NP (5-30μgml(-1) silver concentration), agglomerates of nanoparticles were detected within monocytes (CD14+) but not in T-cells (CD3+) by light microscopy, flow cytometry and combined focused ion beam/scanning electron microscopy. The uptake rate of nanoparticles was concentration dependent, and the silver agglomerates were typically found in the cytoplasm. Furthermore, a concentration-dependent activation (e.g. an increased expression of adhesion molecule CD54) of monocytes at Ag-NP concentrations of 10-15μgml(-1) was observed, and cytotoxicity of Ag-NP-treated monocytes was observed at Ag-NP levels of 25μgml(-1) and higher. However, no modulation of T-cell proliferation was observed in the presence of Ag-NP. Taken together, our results provide the first evidence for a cell-type-specific uptake of Ag-NP by peripheral blood mononuclear cells (PBMC) and the resultant cellular responses after exposure.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Lövestam G, Rauscher H, Roebben G, Klüttgen BS, Putaud J-P, Stamm H. Considerations on a definition of nanomaterial for regulatory purposes. JRC Reference Report 2010.
2. Wijnhoven SWP, Dekkers S, Hagens WI, de Jong WH. Exposure to nanomaterials in consumer products. Letter Report 340370001/2009.
3. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood10.1016/j.biomaterials.2009.03.054 ↗
4. Silver-coated mega endoprostheses in a rabbit model – an analysis of the infection rate and toxicological side effects10.1016/j.biomaterials.2004.01.008 ↗
5. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles10.1093/jac/dkn034 ↗
6. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?10.1093/jac/dkh478 ↗
7. The bactericidal effect of silver naoparticles10.1088/0957-4484/16/10/059 ↗
8. Controlled release of biologically active silver from nanosilver surfaces10.1021/nn102272n ↗
9. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
10. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement10.1016/j.biomaterials.2003.10.078 ↗
11. Antifungal effect of silver nanoparticles on dermatophytes
12. Bacterila infections with silver10.1007/BF01140573 ↗
13. Nano-silver – a review of available data and knowledge gaps in human and environmetal risk assessment10.1080/17435390902725914 ↗
14. Distribution, translocation and accumulation of silver nanoparticles in rats10.1166/jnn.2009.1269 ↗
15. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs)10.1007/s00423-009-0472-1 ↗
16. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells10.1016/j.actbio.2010.08.003 ↗
17. NF-kappaB activation by reactive oxygen species: fifteen years later10.1016/j.bcp.2006.04.011 ↗
18. Metals, toxicity and oxidative stress10.2174/0929867053764635 ↗
19. Toxic metals and oxidative stress. Part I. Mechanisms involved in metal-induced oxidative damage10.2174/1568026013394831 ↗
20. New regulators of NF-kappaB in inflammation10.1038/nri2423 ↗
21. Comparison of cellular functionality of human mesenchymal stromal cells and PBMC10.1080/14653240601011557 ↗
22. Preparation of silver nanoparticles by chemical reduction method10.1016/j.colsurfa.2004.12.058 ↗
23. The toxicity of silver nanoparticles increases during storage due to slow dissolution under release of silver ions10.1021/cm100023p ↗
24. Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque10.1016/0022-1759(74)90109-4 ↗
25. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells10.1016/j.toxlet.2008.04.015 ↗
26. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species10.1021/jp712087m ↗
27. Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis10.1046/j.1365-2249.1999.01021.x ↗
28. Nanosilver – the burgeoning therapeutic molecule and its green synthesis10.1016/j.biotechadv.2009.08.001 ↗
29. The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles10.1039/B914875B ↗
30. Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells10.1002/mabi.200800123 ↗
31. Targeting of nanoparticles to the clathrin-mediated endocytic pathway10.1016/j.bbrc.2006.11.135 ↗
32. 3D imaging of mammalian cells with ion-abrasion scanning electron microscopy10.1016/j.jsb.2008.11.005 ↗
33. Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis10.1021/es0625632 ↗
34. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity10.3109/10408440903453074 ↗
35. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells10.1016/j.biomaterials.2009.01.057 ↗
36. Alberts · 2002
37. Nanoparticles and the immune system10.1210/en.2009-1082 ↗
38. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis10.1042/bj20031253 ↗
39. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate10.1128/AEM.69.7.4278-4281.2003 ↗
40. Nanosilver: a nanoproduct in medical application10.1016/j.toxlet.2007.10.004 ↗
41. Exploitation of intracellular pH gradients in the cellular delivery of macromolecules10.1002/jps.10095 ↗
42. Mechanisms of quantum dot nanoparticle cellular uptake10.1093/toxsci/kfp087 ↗
43. Ion release kinetics and particle persistence in aqueous nano-silver colloids10.1021/es9035557 ↗
44. Nanosilver resonance scattering sprectral method for determination of hydroxyl radical and its application10.1007/s11426-008-0005-8 ↗
45. The mechanism of “Fenton-like” reactions and their importance for biological systems: a biologist’s view
46. Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. doi:10.1007/s00204-010-0545-5.10.1007/s00204-010-0545-5 ↗
47. The effects of nanosilver on the proliferation and cytokine expression by peripheral blood mononuclear cells10.1016/j.intimp.2007.08.025 ↗
48. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes10.1002/smll.200900126 ↗
49. Release of prostaglandin E2, IL-6 and IL-8 from human oral epithelial culture models after exposure to compounds of dental materials10.1034/j.1600-0722.2000.108005442.x ↗
50. Mechanisms of cell activation by heavy metal ions10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H ↗
51. The role of metal corrosion in inflammatory processes: induction of adhesion molecules by heavy metal ions.10.1007/BF00213138 ↗